Bulletin
Investor Alert

Indaptus Therapeutics Inc.

NAS: INDP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 7:53 p.m.

/zigman2/quotes/204811863/composite

$

2.40

Change

-0.35 -12.73%

Volume

Volume 5,853

Quotes are delayed by 20 min

/zigman2/quotes/204811863/composite

Previous close

$ 2.97

$ 2.75

Change

-0.22 -7.41%

Day low

Day high

$2.30

$2.85

Open

52 week low

52 week high

$2.13

$28.83

Open

Annual Financials for Indaptus Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A 829,000859,000854,0008521,403
COGS excluding D&A -----
Depreciation & Amortization Expense 829,000859,000854,0008521,403
Depreciation 829,000859,000854,0008521,403
Amortization of Intangibles -----
Gross Income (829,000)(859,000)(854,000)(852)(1,403)
20172018201920202021 5-year trend
SG&A Expense 28.61M42.47M34.09M3.6M7.73M
Research & Development 24.3M35.4M26.66M2.66M2.52M
Other SG&A 4.32M7.07M7.43M--
Other Operating Expense -----
Unusual Expense (220,000)194,00013.65M--
EBIT after Unusual Expense 220,000(43.52M)(48.6M)--
Non Operating Income/Expense 70,000(747,000)1.32M15,11017,720
Non-Operating Interest Income 286,000852,000330,000--
Equity in Affiliates (Pretax) -----
Interest Expense 17,00023,00015,000--
Gross Interest Expense 17,00023,00015,000--
Interest Capitalized -----
Pretax Income (28.88M)(43.44M)(46.96M)(3.58M)(7.71M)
Income Tax 29,000103,000638,000--
Income Tax - Current Domestic --638,000--
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Minority Interest Expense -----
Net Income (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Preferred Dividends -----
Net Income Available to Common (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
EPS (Basic) (130.96)(111.67)(112.74)(7.37)(1.89)
Basic Shares Outstanding 220,750389,913422,200486,1684.09M
EPS (Diluted) (130.96)(111.67)(112.74)(7.37)(1.89)
Diluted Shares Outstanding 220,750389,913422,200486,1684.09M
EBITDA (28.61M)(42.47M)(34.09M)(3.6M)(7.73M)
Link to MarketWatch's Slice.